The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...

BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...

Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.

The two-time U.S. Olympic gold medalist gymnast opens up about her skin condition, her fashion dos and don’ts for eczema, and ...

The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.

The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...